Skip to main content
. Author manuscript; available in PMC: 2011 Nov 30.
Published in final edited form as: Diabetes Care. 2007 Oct 24;31(2):289–294. doi: 10.2337/dc07-1338

Figure 1.

Figure 1

Changes in glycemia, insulin, and C-peptide. A: Fasting glucose, AUC after an OGTT, and glycated albumin were reduced in salsalate-treated subjects compared with the placebo group. B: The salsalate-treated group (left panel) showed improvements in glycemia after an OGTT compared with the placebo group (right panel). Mean and SEM data are shown before and 30, 60, 90, and 120 min after 75 g oral glucose. ○, baseline data. C and D: Data for insulin (C) and C-peptide (D) are shown before and 30, 60, 90, and 120 min after a 75-g oral glucose load for both the salsalate-treated (left panels) and placebo (right panels) groups. AUC, area under the curve.